Stay updated on Asciminib Combo with Imatinib in CML-CP Clinical Trial
Sign up to get notified when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.

Latest updates to the Asciminib Combo with Imatinib in CML-CP Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedDeleted key study documents and IPD-sharing details from the Study Documents section (including the Statistical Analysis Plan and Study Protocol) along with related metadata and keywords. This removes ready access to primary methodological materials and data-sharing information on the study page.SummaryDifference21%

- Check16 days agoChange DetectedThe website's revision identifier was updated to v3.7.0, reflecting a new build of the site. This appears to be an internal platform update rather than a change to study content or listings.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the study page, indicating a routine update to the page’s revision metadata. This update does not modify the study content or results.SummaryDifference0.0%

- Check37 days agoChange DetectedAn NIH grant/contract identifier (2018) was added to the study's identifiers, updating the funding attribution. This change updates metadata rather than core trial design or results.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page content. This is a minor maintenance update that does not affect the study information or how the page is used.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page's revision label updates from v3.6.3 to v3.6.4, indicating a newer release of the page. This upgrade likely includes minor fixes behind the scenes rather than substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Asciminib Combo with Imatinib in CML-CP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.